Center Publications

Any text in center title
Prahalad, P., et al. “Cgm Initiation Soon After Type 1 Diabetes Diagnosis Results In Sustained Cgm Use And Wear Time.”. Diabetes Care, pp. e3-e4.
Stanford
Tavares, M. R., et al. “Modulation Of Hypothalamic S6K1 And S6K2 Alters Feeding Behavior And Systemic Glucose Metabolism.”. The Journal Of Endocrinology, pp. 71-82.
Michigan
Chiu, C. -H., et al. “Morphomic Factors Associated With Complete Response To Neoadjuvant Therapy In Esophageal Carcinoma.”. The Annals Of Thoracic Surgery, pp. 241-248.
Michigan
Rios-Arce, N. D., et al. “Loss Of Interleukin-10 Exacerbates Early Type-1 Diabetes-Induced Bone Loss.”. Journal Of Cellular Physiology, pp. 2350-2365.
Michigan
Liu, L., et al. “Glycyrrhizin Protects Igfbp-3 Knockout Mice From Retinal Damage.”. Cytokine, p. 154856.
Michigan
Berglund, E., et al. “Safety And Pharmacodynamics Of Anti-Cd2 Monoclonal Antibody Treatment In Cynomolgus Macaques - An Experimental Study.”. Transplant International : Official Journal Of The European Society For Organ Transplantation, pp. 98-107.
Columbia
Weir, G. C. “Glucolipotoxicity, Β-Cells, And Diabetes: The Emperor Has No Clothes.”. Diabetes, pp. 273-278.
Joslin
Alkhouri, N., et al. “Gs-0976 (Firsocostat): An Investigational Liver-Directed Acetyl-Coa Carboxylase (Acc) Inhibitor For The Treatment Of Non-Alcoholic Steatohepatitis (Nash).”. Expert Opinion On Investigational Drugs, pp. 135-141.
Yale
Parikh, L., et al. “Differential Resting State Connectivity Responses To Glycemic State In Type 1 Diabetes.”. The Journal Of Clinical Endocrinology And Metabolism.
Yale
Savage, T. M., et al. “Deletion Of Donor-Reactive T Cell Clones After Human Liver Transplant.”. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons, pp. 538-545.
Columbia
Mooring, M., et al. “Hepatocyte Stress Increases Expression Of Yes-Associated Protein And Transcriptional Coactivator With Pdz-Binding Motif In Hepatocytes To Promote Parenchymal Inflammation And Fibrosis.”. Hepatology (Baltimore, Md.), pp. 1813-1830.
Joslin
Fitchett, D., et al. “Relationship Between Hypoglycaemia, Cardiovascular Outcomes, And Empagliflozin Treatment In The Empa-Reg Outcome® Trial.”. European Heart Journal, pp. 209-217.
Yale
1177 - 1188 of 4935